Welcome to LookChem.com Sign In|Join Free
  • or
(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL is a chemical compound with the molecular formula C6H15NO5Cl. It is a derivative of the naturally occurring amino sugar, D-glucosamine, and has potential applications in the field of medicinal chemistry. (3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL has four hydroxyl groups and a nitrogen atom in its structure, making it suitable for various biological and pharmaceutical studies. It may have potential as an inhibitor or modulator of enzymes and receptors, making it a valuable compound for drug discovery and development. Additionally, its properties as a chiral compound may also make it useful in asymmetric synthesis and the production of pharmaceuticals with specific stereochemistry.

280745-41-7

Post Buying Request

280745-41-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

280745-41-7 Usage

Uses

Used in Medicinal Chemistry:
(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL is used as a potential inhibitor or modulator of enzymes and receptors for drug discovery and development. Its unique structure with hydroxyl groups and a nitrogen atom allows it to interact with biological targets, making it a promising candidate for the treatment of various diseases.
Used in Asymmetric Synthesis:
(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL is used as a chiral compound in asymmetric synthesis, which is crucial for the production of pharmaceuticals with specific stereochemistry. Its unique stereochemistry can be utilized to create enantiomerically pure compounds, which are essential for the development of effective and safe medications.
Used in Pharmaceutical Production:
(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL is used in the production of pharmaceuticals with specific stereochemistry. Its chiral properties make it a valuable building block for the synthesis of enantiomerically pure drugs, which can improve the efficacy and safety of medications.

Check Digit Verification of cas no

The CAS Registry Mumber 280745-41-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,0,7,4 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 280745-41:
(8*2)+(7*8)+(6*0)+(5*7)+(4*4)+(3*5)+(2*4)+(1*1)=147
147 % 10 = 7
So 280745-41-7 is a valid CAS Registry Number.

280745-41-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:280745-41-7 SDS

280745-41-7Relevant academic research and scientific papers

Concise and practical route to tri- and tetra-hydroxy seven-membered iminocyclitols as glycosidase inhibitors from d-(+)-glucurono-γ-lactone

Kalamkar, Navnath B.,Kasture, Vijay M.,Chavan, Sanjay T.,Sabharwal, Sushma G.,Dhavale, Dilip D.

experimental part, p. 8522 - 8526 (2010/11/18)

An efficient and short total synthesis of tetrahydroxy-1c and trihydroxy-azepane 1d is reported in 72% and 57% overall yields, respectively, from d-(+)-glucurono-γ-lactone. Thus, d-glucuronolactone 2 on acetonide protection, DIBAL-H reduction and one-pot intermolecular reductive amination followed by -NCbz protection afforded 6-(N-benzyl-N-benzyloxycarbonyl) amino-6-deoxy-1,2-O-isopropylidene-α-d-gluco-1,4-furanose 5a. 1,2-Acetonide hydrolysis in 5a and Pd-mediated intramolecular reductive aminocyclization afforded tetrahydroxyazepane 1c. An analogous pathway with 5-deoxy-1,2-O-isopropylidene-α-d-glucurono-6,3-lactone 3b gave trihydroxy-azepane 1d. Glycosidase inhibitory activity of 1c/1d was studied and 1d was found to be potent inhibitor of α-mannosidase and β-galactosidase.

Short and efficient synthesis of (2S,3R,4R,5R) and (2S,3R,4R,5S)-tetrahydroxyazepanes via the Henry reaction

Chakraborty, Chaitali,Dhavale, Dilip D.

, p. 912 - 917 (2007/10/03)

The Henry reaction with the easily available α-d-xylo-pentodialdose afforded a diastereomeric mixture of nitroaldoses with the α-d-gluco- and β-l-ido-configuration, respectively, in good yield. When n-BuLi was used as the base, the reaction afforded the α

Syntheses of tetrahydroxyazepanes from chiro-inositols and their evaluation as glycosidase inhibitors

Painter, Gavin F.,Eldridge, Paul J.,Falshaw, Andrew

, p. 225 - 232 (2007/10/03)

Two pairs of C2-symmetric tetrahydroxyazepanes [(-), (+)-1 and (-), (+)-2] have been synthesized from the enantiomeric chiro-inositols and evaluated as glycosidase inhibitors. Alternative syntheses of ido-tetrahydroxyazepanes (-)- and (+)-2 fro

Concise and practical synthesis of (2S,3R,4R,5R) and (2S,3R,4R,5S)-1,6-dideoxy-1,6-iminosugars

Tilekar, Jayant N.,Patil, Nitin T.,Jadhav, Harishchandra S.,Dhavale, Dilip D.

, p. 1873 - 1876 (2007/10/03)

The syntheses of (2S,3R,4R,5R) and (2S,3R,4R,5S)-1,6-dideoxy-1,6 iminosugars 1a and 1b, respectively, from D-glucose are described. The key transformations in this reaction sequence include regio-selective epoxide ring opening with N-benzylamine followed

An easy route to seven-membered iminocyclitols from aldohexopyranosyl enamines

Fuentes, Jose,Gasch, Consolacion,Olano, David,Pradera,Repetto, Guillermo,Sayago, Francisco J.

, p. 1743 - 1753 (2007/10/03)

A new stereocontrolled and high yielding synthesis of biologically active polyhydroxyperhydroazepines is reported starting from easily available glycosylenamines (D-gluco, D-manno, and D-galacto configurations), which are transformed into 1,6-azaanhydropy

Hydroxyazepanes as inhibitors of glycosidase and HIV protease

-

, (2011/05/18)

Hydroxyazepanes display inhibitory activity with respect to glycosidase, with Kivalues from-moderate to low micromolar range. Benzyl and 3,6-dibenzyl derivatives of hydroxyazepanes display inhibitory activity with respect to HIV protease. These compounds are synthesized either by chemoenzymatic or chemical methodologies.

Chemo-enzymatic synthesis of polyhydroxyazepanes

Andreana, Peter R.,Sanders, Tom,Janczuk, Adam,Warrick, Joshua I.,Wang, Peng George

, p. 6525 - 6528 (2007/10/03)

Galactose oxidase (EC 1.1.3.9, GAO) is an extracellular copper-containing enzyme that utilizes molecular oxygen to convert the C6-primary hydroxyl moiety of D-galactopyranosides to hydrated aldehydes. Subsequent dehydratative coupling with hydroxylamines produces oximes (3a-f), which, when subjected to conditions of hydrogenolysis, give rise to polyhydroxyazepanes (11-17).

Short practical synthesis of (3R,4R,5R,6A)-tetrahydroxyazepane and (3S,4S,5S,6S)-trahydroxyazepane from D- And L-chiroinositol, respectively

Painter, Gavin F.,Falshaw, Andrew

, p. 1157 - 1159 (2007/10/03)

The polyhydroxylated azepanes (3R,4R,5R,6R)-tetrahydroxyazepane (-)-l and (35,45,5S,65)-tetrahydroxyazepane (+)-1 are synthesised from D-and L-c/j/ro-inositol, respectively. Key transformations in the reaction sequence include a glycol-fission reaction wi

Seven-membered ring azasugars as glycosidase inhibitors and anticancer agents

Lohray,Bhushan, Vidya,Prasuna,Jayamma,Raheem,Papireddy,Umadevi,Premkumar,Lakshmi,Narayanareddy

, p. 1311 - 1321 (2007/10/03)

Synthesis of various C2 symmetrical tetrahydroxyazepanes has been reported by the reaction of bisepoxides with various primary, amines. The tetrahydroxyazepanes inhibit β-glucosidases in micromolar range and also exhibit anticancer activity in

Synthesis of new N-containing maltooligosaccharides, α-amylase inhibitors, and their biological activities

Uchida, Riichiro,Nasu, Ayako,Tokutake, Shoichi,Kasai, Kouichi,Tobe, Koichiro,Yamaji, Nobuyuki

, p. 187 - 193 (2007/10/03)

Fifteen new N-containing maltooligosaccharides were obtained using the chemoenzymatic method. Among these compounds, maltooligosaccharides having 6- amino-6-deoxy-D-sorbitol residue, (3R,4R,5R,6S)-hexahydro-3,4,5,6- tetrahydroxy-1H-azepine residue, and (3R,5R)-3,4,5-trihydroxypiperidine residue at the reducing end showed strong inhibitory activities for human pancreatic α-amylase (HPA) (EC 3.2.1.1) and human salivary amylase (HSA). The administration of (3R,4R,5R,6S)-hexahydro-3,5,6-trihydroxy-1H-azepine-4- yl O-α-D-glucopyranosyl-(1→4)-α-D-glucopyranoside (13, IC50=4.3x10-5M for HPA, IC50=8.2x10-5M for HSA) and (3R,5R)-3,5-dihydroxypiperidine-4- yl O-α-D-glucopyranosyl-(1→4)-α-D-glucopyranoside (18, IC50=3.4x10-5M for HPA, IC50=4.6 x 10-5 M for HSA) to ICR mice suppressed postprandial hyperglycemia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 280745-41-7